1.Mental Health Competencies in Family Medicine Residency Training
Shogo KAWADA ; Tadao OKADA ; Ryota TAKAHASHI ; Mamiko UKAI
An Official Journal of the Japan Primary Care Association 2021;44(3):116-127
In recent years, the integration of mental health into primary care has become a global trend, as it is recognized to be effective for providing appropriate treatment, improving outcomes, and using resources appropriately. Therefore, in many countries, mental health education in primary care has been developed and delivered. However, systematic training on mental health for family physicians has not been sufficiently provided in Japan. We performed a scoping review in order to clarify the mental health competencies of primary care physicians by analyzing the educational curricula in other countries using thematic analysis. The competencies extracted were comprehensive and classified into three domains: "general competencies in primary care," "general competencies in mental health in primary care," and "specific competencies in mental health in primary care". In the future, it will be necessary to create a competency list based on the reported data and formulate a model curriculum based on the current situation in Japan.
2.Effectiveness of Family-Engaged Multidimensional Team Planning and Management for Recovery in Patients With Severe Stroke and Low Functional Status
Fukumi HIRAGAMI ; Shogo HIRAGAMI ; Yu INOUE
Annals of Rehabilitation Medicine 2019;43(5):581-591
OBJECTIVE: To evaluate the effectiveness of family-engaged multidimensional team planning and management for patients with severe stroke and low functional status and to identify factors predictive of improved outcome at 1 month after admission. METHODS: We retrospectively evaluated 50 patients who underwent family-engaged multidimensional rehabilitation for recovery from severe stroke due to primary unilateral cerebral lesions. The rehabilitation consisted of three phases: comprehensive multidimensional assessment, intensive rehabilitation, and evaluation. Functional Independence Measure (FIM) scores were calculated and used to predict the patients’ status at discharge. RESULTS: Although all FIM scores significantly improved after 1 month of rehabilitation, the motor FIM (mFIM) score improved the most (from 20.5±1.0 to 32.6±2.0). The total FIM (tFIM) and mFIM scores continued to improve from the first month to discharge (mean mFIM efficiency, 0.33). The high-efficiency patient group (mFIM efficiency ≥0.19) had a significantly higher discharge-to-home rate (44% vs. 13%), lower frequency of hemispatial neglect, and more severe finger numbness than the low-efficiency patient group (mFIM efficiency <0.19). The regression analyses revealed that besides lower mFIM and cognitive FIM scores at admission, unilateral spatial neglect, systemic comorbidities, and age were predictive of worse 1-month outcomes and tFIM scores (conformity, R²=0.78; predictive power, Akaike information criterion value=202). CONCLUSION: Family-engaged multidimensional team planning and management are useful for patients with severe stroke and low functional status. Furthermore, FIM scores at admission, age, unilateral spatial neglect, and systemic comorbidities should be considered by rehabilitation teams when advising caregivers on the probability of favorable outcomes after rehabilitation.
Caregivers
;
Cerebrovascular Disorders
;
Comorbidity
;
Fingers
;
Humans
;
Hypesthesia
;
Perceptual Disorders
;
Rehabilitation
;
Retrospective Studies
;
Stroke
;
Symptom Assessment
3.Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee.
Shogo SHIGETA ; Satoru NAGASE ; Mikio MIKAMI ; Masae IKEDA ; Masako SHIDA ; Isao SAKAGUCHI ; Norichika USHIODA ; Fumiaki TAKAHASHI ; Wataru YAMAGAMI ; Nobuo YAEGASHI ; Yasuhiro UDAGAWA ; Hidetaka KATABUCHI
Journal of Gynecologic Oncology 2017;28(6):e76-
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) published the first practice guideline for endometrial cancer in 2006. The JSGO guideline evaluation committee assessed the effect of this guideline introduction on clinical practice and patient outcome using data provided by the Japan Society of Obstetrics and Gynecology (JSOG) cancer registration system. METHODS: Data of patients with endometrial cancer registered between 2000 and 2012 were analyzed, and epidemiological and clinical trends were assessed. The influence of guideline introduction on survival was determined by analyzing data of patients registered between 2004 and 2009 using competing risk model. RESULTS: In total, 65,241 cases of endometrial cancer were registered. Total number of patients registered each year increased about 3 times in the analyzed period, and the proportion of older patients with type II endometrial cancer rapidly increased. The frequency of lymphadenectomy had decreased not only among the low-recurrence risk group but also among the intermediate- or high-recurrence risk group. Adjuvant therapy was integrated into chemotherapy (p<0.001). Overall survival did not significantly differ before and after the guideline introduction (hazard ratio [HR]=0.891; p=0.160). Additional analyses revealed patients receiving adjuvant chemotherapy showed better prognosis than those receiving adjuvant radiation therapy when limited to stage I or II (HR= 0.598; p=0.003). CONCLUSION: It was suggested that guideline introduction influenced the management of endometrial cancer at several aspects. Better organized information and continuous evaluation are necessary to understand the causal relationship between the guideline and patient outcome.
Chemotherapy, Adjuvant
;
Drug Therapy
;
Endometrial Neoplasms*
;
Female
;
Gynecology
;
Humans
;
Japan*
;
Lymph Node Excision
;
Obstetrics
;
Prognosis
4.Effects of Geometrical Uncertainties on Whole Breast Radiotherapy: A Comparison of Four Different Techniques.
Naoki NAKAMURA ; Osamu TAKAHASHI ; Minobu KAMO ; Shogo HATANAKA ; Haruna ENDO ; Norifumi MIZUNO ; Naoto SHIKAMA ; Mami OGITA ; Kenji SEKIGUCHI
Journal of Breast Cancer 2014;17(2):157-160
PURPOSE: The purpose of this study was to quantify the target coverage, homogeneity, and robustness of the dose distributions against geometrical uncertainties associated with four whole breast radiotherapy techniques. METHODS: The study was based on the planning-computed tomography-datasets of 20 patients who underwent whole breast radiotherapy. A total of four treatment plans (wedge, field-in-field [FIF], hybrid intensity-modulated radiotherapy [IMRT], and full IMRT) were created for each patient. The hybrid IMRT plans comprised two opposed tangential open beams plus two IMRT beams. Setup errors were simulated by moving the beam isocenters by 5 mm in the anterior or posterior direction. RESULTS: With the original plan, the wedge technique yielded a high volume receiving > or =107% of the prescription dose (V107; 7.5%+/-4.2%), whereas the other three techniques yielded excellent target coverage and homogeneity. A 5 mm anterior displacement caused a large and significant increase in the V107 (+5.2%+/-4.1%, p<0.01) with the FIF plan, but not with the hybrid IMRT (+0.4%+/-1.2%, p=0.11) or full IMRT (+0.7%+/-1.8%, p=0.10) plan. A 5-mm posterior displacement caused a large decrease in the V95 with the hybrid IMRT (-2.5%+/-3.7%, p<0.01) and full IMRT (-4.3%+/-5.1%, p<0.01) plans, but not with the FIF plan (+0.1%+/-0.7%, p=0.74). The decrease in V95 was significantly smaller with the hybrid IMRT plan than with the full IMRT plan (p<0.01). CONCLUSION: The FIF, hybrid IMRT, and full IMRT plans offered excellent target coverage and homogeneity. Hybrid IMRT provided better robustness against geometrical uncertainties than full IMRT, whereas FIF provided comparable robustness to that of hybrid IMRT.
Breast Neoplasms
;
Breast*
;
Humans
;
Prescriptions
;
Radiotherapy*
;
Radiotherapy, Intensity-Modulated
5.The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
Masae IKEDA ; Masako SHIDA ; Shogo SHIGETA ; Satoru NAGASE ; Fumiaki TAKAHASHI ; Wataru YAMAGAMI ; Hidetaka KATABUCHI ; Nobuo YAEGASHI ; Daisuke AOKI ; Mikio MIKAMI
Journal of Gynecologic Oncology 2021;32(3):e44-
Objective:
The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of the introduction of the first guideline on clinical trends and outcomes of patients with earlystage cervical cancer who underwent surgery.
Methods:
This analysis included 9,756 patients who were diagnosed based on the pathological Tumor-Node-Metastasis (pTNM) classification (i.e., pT1b1, pT1b2, pT2b and pN0, pN1, pNX) and received surgery as a primary treatment between 2004 and 2009. Data of these patients were retrospectively reviewed, and clinicopathological trends were assessed.The influence of the introduction of the guideline on survival was determined by using a competing risk model.
Results:
For surgery cases, the estimated subdistribution hazard ratio (HR) by the competing risk model for the influence of the guideline adjusted for age, year of registration, pT classification, pN classification, histological type, and treatment methods was 1.024 (p=0.864). Following the introduction of the first guideline in 2007, for patients with lymph node metastasis, the use of chemotherapy (CT) as a postsurgical therapy increased, whereas that of concurrent chemoradiotherapy (CCRT)/radiotherapy (RT) decreased (p<0.010). For pN1 cases, the estimated subdistribution HR by the competing risk model for the influence of the guideline was 1.094 (p=0.634). There was no significance in the postsurgical therapy between CT and CCRT/RT (p=0.078).
Conclusions
Survival of surgical cases was not improved by the introduction of the guidelines. It is necessary to consider more effective postsurgical therapy for high-risk earlystage cervical cancer.
6.Dynamic Cervical Spinal Canal Stenosis: Identifying Imaging Risk Factors in Extended Positions
Shogo MATSUMOTO ; Ryoma AOYAMA ; Junichi YAMANE ; Ken NINOMIYA ; Yuichiro TAKAHASHI ; Kazuya KITAMURA ; Satoshi NORI ; Satoshi SUZUKI ; Ukei ANAZAWA ; Tateru SHIRAISHI
Asian Spine Journal 2024;18(2):227-235
Methods:
This study analyzed 143 patients who underwent decompression surgery between 2012 and 2014, who had symptomatic cervical disorders and MRI evidence of spinal cord or nerve compression but had no history of cervical spine surgery. Patient demographics, disease type, Japanese Orthopedic Association score, and follow-up periods were recorded. Spinal surgeons conducted radiological evaluations to determine stenosis levels using computed tomography myelography or MRI in neutral and extended positions. Measurements such as dural tube and spinal cord diameters, cervical alignment, range of motion, and various angles and distances were also analyzed. The residual space available for the spinal cord (SAC) was also calculated.
Results:
During extension, new stenosis frequently appeared caudal to the stenosis site in a neutral position, particularly at C5/C6 and C6/C7. A low SAC was identified as a significant risk factor for the development of new stenosis in both the upper and lower adjacent disc levels. Each 1-mm decrease in SAC resulted in an 8.9- and 2.7-fold increased risk of new stenosis development in the upper and lower adjacent disc levels, respectively. A practical SAC cutoff of 1.0 mm was established as the threshold for new stenosis development.
Conclusions
The study identified SAC narrowing as the primary risk factor for new stenosis, with a clinically relevant cutoff of 1 mm. This study highlights the importance of local factors in stenosis development, advocating for further research to improve outcomes in patient with cervical spine disorders.
7.Effects of Histamine-2 Receptor Antagonists and Proton Pump Inhibitors on the Rate of Gastric Emptying: A Crossover Study Using a Continuous Real-Time 13C Breath Test (BreathID System).
Takashi NONAKA ; Takaomi KESSOKU ; Yuji OGAWA ; Kento IMAJYO ; Shogo YANAGISAWA ; Tadahiko SHIBA ; Takashi SAKAGUCHI ; Kazuhiro ATSUKAWA ; Hisao TAKAHASHI ; Yusuke SEKINO ; Eiji SAKAI ; Takashi UCHIYAMA ; Hiroshi IIDA ; Kunihiro HOSONO ; Hiroki ENDO ; Yasunari SAKAMOTO ; Koji FUJITA ; Masato YONEDA ; Tomoko KOIDE ; Hirokazu TAKAHASHI ; Chikako TOKORO ; Yasunobu ABE ; Eiji GOTOH ; Shin MAEDA ; Atsushi NAKAJIMA ; Masahiko INAMORI
Journal of Neurogastroenterology and Motility 2011;17(3):287-293
BACKGROUND/AIMS: The effects of Histamine-2 receptor antagonists and proton pump inhibitors on the gastrointestinal motility have not yet been sufficiently investigated. The aim of this study was to determine the effects of intravenous bolus administration of famotidine and omeprazole on the rate of gastric emptying using the continuous 13C breath test (BreathID system, Exalenz Bioscience Ltd, Israel). METHODS: Twelve healthy male volunteers participated in this randomized, 3-way crossover study. After fasting overnight, the subjects were randomly assigned to receive 20 mg of famotidine, 20 mg of omeprazole or 20 mL of saline alone by intravenous bolus injection before a test meal (200 kcal per 200 mL, containing 100 mg of 13C-acetate). Gastric emptying was monitored for 4 hours after the ingestion of test meal by the 13C-acetic acid breath test performed using the BreathID system. RESULTS: No significant differences in the calculated parameters, namely, the T1/2, Tlag, GEC, beta and kappa, were observed among the 3 test conditions. CONCLUSIONS: The study revealed that intravenous administration of gastric acid suppressant drugs had no significant influence on the rate of gastric emptying in comparison with that of saline alone as a placebo. Our results indicating the absence of any effect of either famotidine or omeprazole on accelerating the rate of gastric emptying suggest that both medications can be administered safely to patients suffering from hemorrhagic peptic ulcers who need to be kept nil by mouth from the viewpoint of possible acceleration of gastrointestinal motility in the clinical setting.
Acceleration
;
Administration, Intravenous
;
Breath Tests
;
Cross-Over Studies
;
Eating
;
Famotidine
;
Fasting
;
Gastric Acid
;
Gastric Emptying
;
Gastrointestinal Motility
;
Humans
;
Male
;
Meals
;
Mouth
;
Omeprazole
;
Peptic Ulcer
;
Proton Pump Inhibitors
;
Proton Pumps
;
Protons
;
Stress, Psychological
8.Comparative Study of 2 Different Questionnaires in Japanese Patients: The Quality of Life and Utility Evaluation Survey Technology Questionnaire (QUEST) Versus the Frequency Scale for the Symptoms of Gastroesophageal Reflux Disease Questionnaire (FSSG).
Takashi NONAKA ; Takaomi KESSOKU ; Yuji OGAWA ; Shogo YANAGISAWA ; Tadahiko SHIBA ; Takashi SAKAGUCHI ; Kazuhiro ATSUKAWA ; Hisao TAKAHASHI ; Yusuke SEKINO ; Hiroshi IIDA ; Hiroki ENDO ; Yasunari SAKAMOTO ; Tomoko KOIDE ; Hirokazu TAKAHASHI ; Masato YONEDA ; Shin MAEDA ; Atsushi NAKAJIMA ; Eiji GOTOH ; Masahiko INAMORI
Journal of Neurogastroenterology and Motility 2013;19(1):54-60
BACKGROUND/AIMS: The aim of this study was to examine the convenience of the quality of life and utility evaluation survey technology (QUEST) questionnaire and the frequency scale for the symptoms of gastroesophageal reflux disease (FSSG) questionnaire as self-assessment diagnostic instrument. METHODS: This was a two-way crossover study conducted over 6 weeks from September 2010 to November 2010. The subjects were 60 consecutive patients admitted to the Hiratsuka city hospital with a gastrointestinal condition, regardless of the coexistence of heartburn. They were assigned to fill in both the QUEST and FSSG questionnaires in random order. We analyzed the time taken to complete the questionnaires, whether subjects asked any questions as they filled in the questionnaire, and the questionnaire scores. RESULTS: Comparison of the QUEST and the FSSG revealed significant differences in the completion time (196.5 vs. 97.5 seconds, respectively; P < 0.0001) and in whether subjects asked any questions (37 vs. 15 subjects, respectively; P < 0.0001). Completion time in QUEST scores of > or = 4 was lower than < 4 (170.5 vs. 214.0 seconds, respectively; P = 0.022), and the QUEST score was significantly higher without questions than with question (3 vs. 1 points, respectively; P = 0.025). CONCLUSIONS: This study revealed that the FSSG questionnaire may be easier for Japanese subjects to complete than the QUEST questionnaire.
Asian Continental Ancestry Group
;
Cross-Over Studies
;
Gastroesophageal Reflux
;
Heartburn
;
Hospitals, Urban
;
Humans
;
Quality of Life
;
Surveys and Questionnaires
;
Self-Assessment
9.Crosstalk between CYP2E1 and PPARα substrates and agonists modulate adipose browning and obesity.
Youbo ZHANG ; Tingting YAN ; Tianxia WANG ; Xiaoyan LIU ; Keisuke HAMADA ; Dongxue SUN ; Yizheng SUN ; Yanfang YANG ; Jing WANG ; Shogo TAKAHASHI ; Qiong WANG ; Kristopher W KRAUSZ ; Changtao JIANG ; Cen XIE ; Xiuwei YANG ; Frank J GONZALEZ
Acta Pharmaceutica Sinica B 2022;12(5):2224-2238
Although the functions of metabolic enzymes and nuclear receptors in controlling physiological homeostasis have been established, their crosstalk in modulating metabolic disease has not been explored. Genetic ablation of the xenobiotic-metabolizing cytochrome P450 enzyme CYP2E1 in mice markedly induced adipose browning and increased energy expenditure to improve obesity. CYP2E1 deficiency activated the expression of hepatic peroxisome proliferator-activated receptor alpha (PPARα) target genes, including fibroblast growth factor (FGF) 21, that upon release from the liver, enhanced adipose browning and energy expenditure to decrease obesity. Nineteen metabolites were increased in Cyp2e1-null mice as revealed by global untargeted metabolomics, among which four compounds, lysophosphatidylcholine and three polyunsaturated fatty acids were found to be directly metabolized by CYP2E1 and to serve as PPARα agonists, thus explaining how CYP2E1 deficiency causes hepatic PPARα activation through increasing cellular levels of endogenous PPARα agonists. Translationally, a CYP2E1 inhibitor was found to activate the PPARα-FGF21-beige adipose axis and decrease obesity in wild-type mice, but not in liver-specific Ppara-null mice. The present results establish a metabolic crosstalk between PPARα and CYP2E1 that supports the potential for a novel anti-obesity strategy of activating adipose tissue browning by targeting the CYP2E1 to modulate endogenous metabolites beyond its canonical role in xenobiotic-metabolism.